TRISPAN (USA) LLC

Thesis

TriSpan (USA) LLC is a transatlantic private equity firm founded in 2015, with offices in New York and London. They focus on opportunistic private equity investments in growth businesses, aiming for strong returns with low volatility. The firm targets lower to middle-market companies in North America, Europe, and the UK, with annual revenues between $20-100 million and/or EBITDA of $2-20 million. Their investment strategy is flexible and hands-on, targeting companies with growth potential, attractive industry dynamics, and solid cash generation. The 'Opportunities Fund' is sector-agnostic but favors buy-and-build strategies in Business Services, Multi-Unit Healthcare Services, and Specialty Manufacturing. The 'Rising Stars' strategy focuses on control-oriented growth investments in differentiated, high-growth restaurant concepts. TriSpan invests across full buyouts, partial buyouts, and growth capital, and can take control to passive roles. They emphasize a partnership approach, creating value through operational and financial expertise. As of December 31, 2025, AUM was approximately $1.125 billion, with another source indicating $658.9 million. The firm has invested approximately $5 billion in over 130 companies globally. They have a specific focus on companies with EBITDA between $5M – $20M for their 'Opportunities Fund'.

Related lists

• Series C+ investors based in New York, NY